Valued at USD 7.74 billion in 2024, the arrhythmia market is projected to reach USD 8.24 billion in 2025 and USD 14.59 billion by 2034, growing at a CAGR of 6.6% during the forecast period 2025–2034. Growth is driven by lifestyle factors such as smoking, excessive alcohol consumption and obesity, along with rising patient awareness. Key players include Applied Cardiac Systems, AliveCor,...